Stay updated on INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies
Sign up to get notified when there's something new on the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page.

Latest updates to the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now displays a 403 Forbidden error page, replacing the usual study details. A simple header with 403 and a Home button is shown, indicating that access to the content is blocked.SummaryDifference22%

- Check19 days agoChange DetectedA new page revision tag (Revision: v3.7.0) and accompanying date stamps were added, and the 'Find contact information' label was changed from 'Find Contact Information' to 'Find contact information'. These are cosmetic metadata and UI text changes that do not alter study content, eligibility criteria, or data presented on the page.SummaryDifference0.2%

- Check33 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing Revision: v3.6.5, signaling a small page update or QA refresh rather than a substantive change to study data.SummaryDifference0.0%

- Check40 days agoChange DetectedA new identifier, '2023 ( U.S. NIH Grant/Contract )', was added under the study's Other Study ID Numbers to reflect NIH funding/identification associated with the trial.SummaryDifference0.0%

- Check47 days agoChange DetectedRecruitment status changed to Completed as of 2026-08-17, indicating enrollment across sites has ended. This reflects a milestone update on the study page relevant to participants and researchers.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.6.5 appears on the page, replacing the previous v3.6.4. This indicates a small platform/template update rather than a change to study information.SummaryDifference0.0%

Stay in the know with updates to INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies
Enter your email address, and we'll notify you when there's something new on the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page.